Search
Wednesday 6 January 2016
  • :
  • :

3 Best Stocks Under Review: Encana (NYSE:ECA), United States Steel (NYSE:X), St. Jude Medical (NYSE:STJ)

On Wednesday, Encana Corporation (USA) (NYSE:ECA)’s shares declined -7.83% to $7.65.

ECA has 67.20% institutional ownership while its EPS ratio was -5.37. The company has 845.67 million shares outstanding while market capitalization of the company was $7.02 billion. Price to book ratio was 0.96. Net profit margin of the company was -77.10% while gross profit margin was 73.80%. Stock volatility for the month was booked as 4.74% while for the week was recorded as 5.68%. The mean estimate for the short term price target for Encana Corporation (USA) (NYSE:ECA) stands at $11.07 according to 26 Analysts. The higher price target estimate for the stock has been calculated at $20.00 while the lower price target estimate is at $8.00 Encana Corporation (USA) (NYSE:ECA) is engaged in the business of the exploration, development, production and marketing of natural gas, oil and natural gas liquids (NGLs). The Company operates through three business segments:

United States Steel Corporation (NYSE:X)’s shares dropped -4.20% to $7.75.

So far in 2015, the company has a year-to-date performance of -71.02%. The stock, as of last close, traded 3.20% up from its 52 week low and was -76.20% below its 52 week high. Its latest closing price was -58.82% below the SMA200 while the distance from SMA 50 and SMA 20 was -27.48% and -19.28% respectively. The mean estimate for the short term price target for United States Steel Corporation (NYSE:X) stands at $13.62 according to 15 Analysts. The higher price target estimate for the stock has been calculated at $30.00 while the lower price target estimate is at $3.00. United States Steel Corporation (NYSE:X) is a steel producer. The Company is engaged in producing flat-rolled and tubular products with production operations in North America and Europe. The Company operates through three segments:

At the end of Wednesday’s trade, St. Jude Medical, Inc. (NYSE:STJ)‘s shares dipped -0.02% to $62.97.

STJ has market capitalization of $17.80 billion. Its current ratio was 1.70 while its shares were below its 50 days simple moving average with -1.51%. The company offered earning per share of $3.52 while its 282.66 million shares were outstanding. YTD performance of the company was -3.17%. Stock volatility for the week was 1.34% while for the month it was shown at 1.65% The mean estimate for the short term price target for St. Jude Medical, Inc. (NYSE:STJ) stands at $74.45 according to 22 Analysts. The higher price target estimate for the stock has been calculated at $89.00 while the lower price target estimate is at $59.00. St. Jude Medical, Inc. (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *